Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.26 (
invertase
)
4,927
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A solution of 10 g/L of sodium alginate (Satialgine types used [Sanofi trademark]: SG800 and S1100 with manuronic/guluronic ratio of 0.5 and 1.2, respectively) containing
invertase
(0.08 g of protein/L) was dropped into 0.1 M CaCl2 solution buffered at pH 4.0, 7.0, or 8.0. The beads were left to harden in CaCl2 solution for 24 h. The high immobilization yield of 60% occurred with SG800 at pH 8.0. The activity of soluble and insoluble
invertase
was measured against pH (2.8-8.0), sucrose concentration (4.5-45 mM), and temperature (30-60 degrees C). Both forms presented an optimum pH of 4.6. However, the soluble
invertase
was stable at the overall pH interval studied, whereas insoluble
invertase
lost 30% of its original activity at pH > 5.0. At temperatures above 40 degrees C, the insoluble form was more stable than the soluble one. The kinetic constants and activation energies (Ea) for free
invertase
were KM = 41.2 mM, Vmax = 0.10 mg of
TRS
/(min.mL), and Ea 28 kJ/mol for entrapped
invertase
they were (KM)ap = 7.2 mM, (Vmax)ap = 0.060 mg of
TRS
/(min.mL), and (Ea)ap = 24 kJ/mol.
...
PMID:Characterization of invertase entrapped into calcium alginate beads. 1053 12